WEEKLY MARKET DIGEST: HERE IS WHAT SMART MONEY IS DOING WITH STOCKS, GOLD, OIL AND MARIJUANA $DIA $GLD $QQQ $SLV $SPY $TBT $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the ...
Read more »

WEEKLY MARKET DIGEST: SHORT SQUEEZE AND QUADRUPLE WITCHING STOCK MARKET RALLY FAILED AS WE HAD CALLED $DIA $GLD $QQQ $SLV $SPY $USO

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

CHLOROQUINE CAN POTENTIALLY TRIGGER A 5000 POINT RALLY IN THE STOCK MARKET $AAL $AAPL $AMD $AMZN $BAC $DIA $DJIA $GILD $INTC $JPM $LUV $MYL $SPX $TEVA $BAYRY

Investors, after facing huge losses amid the threat of the coronavirus, are grappling with what is next for the stock market. In January, I warned that an external event could cause a major drop in the market. Now ...
Read more »

A NEW IDEA ON BIOTECH COMPANY ACORDA ON PATENT INVALIDATION $ACOR $MYL $TEVA

These posts were published on ZYX Short Sell Change Alert. The short zone for Acorda Therapeutics (ACOR) is $24.50 to $26.40.  Since the stock is moving fast we want to get this to you quickly.  We will do ...
Read more »

You are receiving less than 2% of the content from our paid services ...TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE 30 day trial.

Check out our enviable performance in both bull and bear markets.

BE FOREWARNED IF YOU ARE CHASING DIVIDENDS $TEVA $MYL $PRGO $RDY $ABX $MCK $CAH $ESRX

  Dividend-chasing is in vogue. Given low interest rates, many investors say they have no other choice. Such thinking leads to costly mistakes. It just badly hurt those who had bought shares of Teva Pharmaceutical Industries TEVA,  because ...
Read more »

TRUMP’S ‘OBAMACARE LITE’ PRESENTS OPPORTUNITIES AND PERILS FOR INVESTORS $XBI $MDT $BSX $EW $CYH $THC $PFE $JNJ $MRK $BMY $TEVA $MYL

Republicans have finally produced a detailed plan to repeal and replace the Affordable Care Act, also known as Obamacare. Setting aside politics and viewing the plan neutrally, two things jump out. First, the House Republicans’ plan ...
Read more »

A NEW IDEA ON MOMENTA, AFTER RECENT GAIN OF 74% THE DIP IS AN OPPORTUNITY TO ENTER AGAIN $MNTA $TEVA $PFE

This post was just published on ZYX Buy Change Alert. On February 1st we issued a call to take profits on MNTA.  Depending upon how you traded, your profits would have been 74%. We got out at the top.  ...
Read more »

MOMENTA PHARMACEUTICALS JUMPS ON COPAXONE RULING, TAKE PROFITS AND EXIT THE POSITION IF STILL HOLDING $MNTA $MYL $TEVA

This post was published on ZYX Buy Change Alert. MNTA has an average price of $11.31.  As of this writing it is trading at $19.05. The stock has jumped on a court invalidating TEVA patent on a MS ...
Read more »

MYLAN BENEFITING FROM COPAXONE $MYL $TEVA

This post was just published on ZYX Buy Change Alert. MYL is benefiting from invalidation of TEVA patent on Copaxone, an MS drug.  The new buy zone is $32 to $35.57.  Recommended position size is 35% to 40%.  ...
Read more »

PLAN ON MYLAN: TEVA PHARMACEUTICAL, TAX LOSS SELLING AND TRUMP $MYL $TEVA

This post was just published on ZYX Buy Change Alert. TEVA MYL is a generic drug manufacturer.  The earlier decline in the stock was in sympathy with TEVA.  TEVA is the largest generic drug manufacturer in the world.  TEVA's ...
Read more »
12
Follow

Get every new post delivered to your Inbox

Join other followers